Effects of early nutritional interventions on the development of atopic disease in children Major Recommendations The following recommendations summarise the current evidence related to allergy prevention through dietary interventions, keeping in mind that some aspects are currently uncertain due to inadequate study design or paucity of data. 1. There is a current lack of evidence […]
Supplementation of infant formula with probiotics / prebiotics
December 1, 2011 by 1 Comment
Infant formulae are increasingly being supplemented with probiotics, prebiotics, or both (see box for definitions). Recommendations for using probiotic- and/or prebiotic-supplemented formulae should be determined by their nutritional adequacy, potential short- and long-term benefits, and safety of continued administration. The Committee on Nutrition of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) systematically […]
Vitamin D status among adolescents in Europe
December 1, 2011 by Leave a Comment
New results from the HELENA study show that vitamin D deficiency is a highly prevalent condition in European adolescents. HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) is a wide-ranging project financially supported by the European Union, which is designed to understand and enhance nutritional and lifestyle habits of adolescents in Europe. The nutritional […]
Pradaxa and Renal Function
December 1, 2011 by Leave a Comment
Pradaxa (dabigatran etexilate) – Recommendations for assessment of renal function and monitoring in the elderly Pradaxa (dabigatran etexilate) is a potent, competitive, reversible direct thrombin inhibitor, which was authorised through an EU assessment procedure and is currently licensed for use in the following indications: - Primary prevention of venous thromboembolic events in adults who have […]
Co-Vatan
December 1, 2011 by Leave a Comment
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredients: Valsartan/HCTZ 80mg/12.5mg, 160/12.5mg, 160/25mg. Description: 80mg/12.5mg: Light orange. 160/12.5mg: Dark red. 160/25mg: Brown orange. Oval, film-coated tablets marked HGH, HHH or HXH on one side and CG, CG or NVR on reverse, respectively. Presentation: 80/12.5mg-28, €16.16; 160/12.5mg-28, €21.11; 160/25mg-28, €21.83. Indication: Treatment of essential […]
Menopur
December 1, 2011 by Leave a Comment
Company: Ferring Ireland Ltd. Legal category: Prescription. High Tech. Sport prohibited in men only. Active ingredients: Menotrophin (human menopausal gonadotrophin HMG) 600IU, 1200IU. 600IU: 600IU human follicle stimulating hormone (FSH) and 600IU human luteinising hormone (LH). 1200IU: 1200IU FSH and 1200IU LH. Description: Powder and solvent for solution for injection. Presentation: 600IU, €170.75; 1200IU, €341.51. […]
Pegasys
December 1, 2011 by Leave a Comment
Company: Roche Products (Ireland) Ltd. Legal category: Prescription. High Tech. Sport permitted. Active ingredient: Peginterferon alfa-2a 135mcg, 180mcg. Description: 0.5ml solution in pre-filled pen. Presentation: 135mcg-1; 180mcg-4. Prices on request. Indications: Treatment of HBeAg-positive or HBeAg-negative chronic hepatitis B. Treatment of chronic hepatitis C, including patients with compensated cirrhosis/co-infected with clinically stable HIV, with optimal […]
Prostap 6 DCS
December 1, 2011 by Leave a Comment
Company: Takeda UK Ltd. Legal category: Prescription. High Tech. Sport prohibited in men only. Active ingredient: Leuprorelin acetate 30mg. Description: Powder and solvent for prolonged-release suspension for injection in dual chamber pre-filled syringe. Presentation: 1, €625.57. Indications: Metastatic prostate cancer. Locally advanced prostate cancer, as an alternative to surgical castration. As an adjuvant treatment to […]
Saizen
December 1, 2011 by Leave a Comment
Company: Merck Serono (Ireland) Ltd. Legal category: Prescription. High Tech. Sport prohibited. Active ingredient: Somatropin 5.83mg/ml, 8mg/ml. Description: Solution for injection. Presentation: 5.83mg/ml x 1.03ml (6mg), €169.49; 8mg/ml x 1.5ml (12mg), €338.98; 8mg/ml x 2.5ml (20mg), €564.97. Indications: Growth failure in children due to growth hormone (GH) deficiency; in girls with Turner syndrome; in prepubertal […]
Tobi Podhaler
December 1, 2011 by Leave a Comment
Company: Novartis Ireland Ltd. Legal category: Prescription. High Tech. Sport permitted. Active ingredient: Tobramycin 28mg. Description: Inhalation powder in hard capsules marked NVR AVCI and with Novartis logo. Presentation: Monthly pack (4 weekly cartons – each containing 56 capsules and a Podhaler inhalation device – and a reserve Podhaler inhalation device), €2505.20. Indications: Suppressive therapy […]
Loading ...
